Bristol-Myers Squibb Co.

Pharmaceuticals
United States
Earnings Per Share Growth (%)-22.50%
Cost of Goods Sold (US$ Millions)$3,909
Current Liabilities (US$ Millions)$8,017
Total Assets (US$ Millions)$10,415
Long Term Debt$6,550
Return on Equity10.54%
Revenue (US$ Millions)$16,560
Total Company Assets$31,748
Revenue Growth (%)4.29%
Net Income (US$ Millions)$1,565
Earnings Per Share (US$)($22.50)
Total Equity (US$ Millions)$14,266
Profit Margin (%)9.45%
Debt To Equity Ratio (%)0.46%
Inventory Turnover$1,221